Literature DB >> 8752086

The ion-induced folding of the hammerhead ribozyme: core sequence changes that perturb folding into the active conformation.

G S Bassi1, A I Murchie, D M Lilley.   

Abstract

The hammerhead ribozyme undergoes an ion-dependent folding process into the active conformation. We find that the folding can be blocked at specific stages by changes of sequence or functionality within the core. In the the absence of added metal ions, the global structure of the hammerhead is extended, with a large angle subtended between stems I and II. No core sequence changes appear to alter this geometry, consistent with an unstructured core under these conditions. Upon addition of low concentrations of magnesium ions, the hammerhead folds by an association of stems II and III, to include a large angle between them. This stage is inhibited or altered by mutations within the oligopurine sequence lying between stems II and III, and folding is completely prevented by an A14G mutation. Further increase in magnesium ion concentration brings about a second stage of folding in the natural sequence hammerhead, involving a reorientation of stem I, which rotates around into the same direction of stem II. Because this transition occurs over the same range of magnesium ion concentration over which the hammerhead ribozyme becomes active, it is likely that the final conformation is most closely related to the active form of the structure. Magnesium ion-dependent folding into this conformation is prevented by changes at G5, notably removal of the 2'-hydroxyl group and replacement of the base by cytidine. The ability to dissect the folding process by means of sequence changes suggests that two separate ion-dependent stages are involved in the folding of the hammerhead ribozyme into the active conformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752086      PMCID: PMC1369413     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  21 in total

1.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  Cold denaturation of the hammerhead ribozyme.

Authors:  Peter J Mikulecky; Andrew L Feig
Journal:  J Am Chem Soc       Date:  2002-02-13       Impact factor: 15.419

3.  Entropy-driven folding of an RNA helical junction: an isothermal titration calorimetric analysis of the hammerhead ribozyme.

Authors:  Peter J Mikulecky; Jennifer C Takach; Andrew L Feig
Journal:  Biochemistry       Date:  2004-05-18       Impact factor: 3.162

4.  Coordination environment of a site-bound metal ion in the hammerhead ribozyme determined by 15N and 2H ESEEM spectroscopy.

Authors:  Matthew Vogt; Simanti Lahiri; Charles G Hoogstraten; R David Britt; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

5.  Cryoenzymology of the hammerhead ribozyme.

Authors:  A L Feig; G E Ammons; O C Uhlenbeck
Journal:  RNA       Date:  1998-10       Impact factor: 4.942

6.  The P15-loop of Escherichia coli RNase P RNA is an autonomous divalent metal ion binding domain.

Authors:  J Kufel; L A Kirsebom
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

Review 7.  Hammerhead ribozyme kinetics.

Authors:  T K Stage-Zimmermann; O C Uhlenbeck
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

8.  Effects of polyvalent cations on the folding of an rRNA three-way junction and binding of ribosomal protein S15.

Authors:  R T Batey; J R Williamson
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

9.  Ion-induced folding of the hammerhead ribozyme: a fluorescence resonance energy transfer study.

Authors:  G S Bassi; A I Murchie; F Walter; R M Clegg; D M Lilley
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

10.  Liposome membrane can induce self-cleavage of RNA that models the core fragments of hammerhead ribozyme.

Authors:  Keishi Suga; Seishiro Tanaka; Hiroshi Umakoshi
Journal:  Eur Biophys J       Date:  2015-09-18       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.